The present disclosure relates to a composition for increasing the expression of a growth factor gene, which contains core-shell structured microparticles as an active ingredient. When administered in vivo along with a growth factor gene, the composition for increasing the expression of a growth factor gene of the present disclosure can increase the expression of the co-administered gene by at least 30%. Especially, when administered along with at least one gene selected from a human hepatocyte growth factor (HGF) gene, an isoform gene of the human hepatocyte growth factor and a variant gene thereof, or at least one gene selected from a human insulin-like growth factor 1 (IGF1) gene, an isoform gene of the human insulin-like growth factor 1 and a variant gene thereof, which are appropriate for the present disclosure, the composition can increase the expression of the gene by at least 30%. When administered along with a gene therapeutic agent, the composition can achieve a therapeutic effect even with a very small amount of a gene, and thus is useful.

Described herein are methods of treating or preventing genital warts comprising administering to a subject a therapeutically effective amount of a vaccine against human papillomavirus (HPV) and reducing exposure of an area susceptible to genital warts to moisture, to non-neutrally electrically charged materials, or a combination thereof. Also described are kits or articles of manufacture for use in treating or preventing genital warts.

Described herein are methods of treating or preventing genital warts comprising administering to a subject a therapeutically effective amount of a vaccine against human papillomavirus (HPV) and reducing exposure of an area susceptible to genital warts to moisture, to non-neutrally electrically charged materials, or a combination thereof. Also described are kits or articles of manufacture for use in treating or preventing genital warts.

Described herein are methods of treating or preventing plantar warts comprising administering to a subject a therapeutically effective amount of a vaccine against human papillomavirus (HPV) and reducing exposure of an area susceptible to plantar warts to moisture, to non-neutrally electrically charged materials, or a combination thereof. Also described are kits or articles of manufacture for use in treating or preventing plantar warts.

The present invention provides a preparation for attaching to teeth or tooth peripheries. The preparation for attaching to teeth or tooth peripheries of the present invention can give high adhesive force to the desired site despite interproximal space or curves of teeth. It is easy to hand while controlling drug release.

The present invention provides a preparation for attaching to teeth or tooth peripheries. The preparation for attaching to teeth or tooth peripheries of the present invention can give high adhesive force to the desired site despite interproximal space or curves of teeth. It is easy to hand while controlling drug release.

The present invention provides: a complex of a mercaptoundecahydrodecaborate (BSH) and a peptide, the complex for boron neutron capture therapy (BNCT); a method for producing the complex; and a cancer therapy using the complex.

A microcapsule composition comprising at least one polymer substantially disposed as a semipermeable shell around an aqueous buffered solution and at least one agent, wherein the agent permeates the shell, and wherein the composition is suitable for delivery to a mammal.

A microcapsule composition comprising at least one polymer substantially disposed as a semipermeable shell around an aqueous buffered solution and at least one agent, wherein the agent permeates the shell, and wherein the composition is suitable for delivery to a mammal.

The present invention provides: a complex of a mercaptoundecahydrodecaborate (BSH) and a peptide, the complex for boron neutron capture therapy (BNCT); a method for producing the complex; and a cancer therapy using the complex.